SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001144204-19-037891
Filing Date
2019-08-06
Accepted
2019-08-06 16:30:28
Documents
3
Period of Report
2019-08-06

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tv526667_6k.htm 6-K 14471
2 EXHIBIT 99.1 tv526667_ex99-1.htm EX-99.1 5587
3 GRAPHIC tv526667_logo.jpg GRAPHIC 4498
  Complete submission text file 0001144204-19-037891.txt   27367
Mailing Address VALLONGATAN 1 UPPSALA V7 752 28
Business Address VALLONGATAN 1 UPPSALA V7 752 28 011 46 18 50 54 40
Oasmia Pharmaceutical AB (Filer) CIK: 0001607245 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V7 | Fiscal Year End: 0430
Type: 6-K | Act: 34 | File No.: 001-37604 | Film No.: 191002492
SIC: 2834 Pharmaceutical Preparations